Literature DB >> 8418116

A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly.

M Bowden1, J Crawford, H J Cohen, O Noyama.   

Abstract

OBJECTIVE: To define the prevalence of monoclonal immunoglobulin (Ig) proteins and quantitative serum immunoglobulin levels in elderly Japanese in comparison with elderly Caucasians as possible factors related to the reported lower incidence of multiple myeloma in elderly Japanese than in elderly Caucasians.
DESIGN: Survey study
SETTING: Community Center in Yokohama, Japan and Retirement Community in the United States. PARTICIPANTS: Convenience sample of community-dwelling elderly subjects (age 63-95) presenting for health screening examinations in each setting. Frozen serum samples were obtained from routine screening from 146 consecutive Japanese subjects and 111 US subjects. INTERVENTION: None MEASUREMENTS: Presence of monoclonal immunoglobulin protein determined by serum protein electrophoresis and immunofixation and quantitative Ig by laser nephelometry.
RESULTS: Four (2.7%) of the Japanese cohort had monoclonal gammopathies compared with 11 (10%) of the American cohort. Two of the monoclonal gammopathies were IgG Kappa and two were IgG Lambda. No cases of multiple monoclonal gammopathy were identified in the Japanese group, compared with 25% of the monoclonal gammopathies in the American group. The mean quantitative serum IgG level for the Japanese group was 1,685 +/- 520 mg/dL versus 1,118 +/- 402 mg/dL for the American group; mean quantitative IgA levels were 283 +/- 116 mg/dL versus 226 +/- 116 mg/dL (P < 0.001). Albumin levels were normal in both populations, suggesting that there was not an increase in occult inflammatory disorders in the Japanese population.
CONCLUSION: The low prevalence of monoclonal gammopathy in elderly Japanese is consistent with the reported lower frequency of multiple myeloma. The reason for the higher quantitative immunoglobulin levels in this population is unclear. Further cross-cultural investigation is warranted to explore the genetic influences on altered immune regulation with aging.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418116     DOI: 10.1111/j.1532-5415.1993.tb05940.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  10 in total

1.  Elucidating disparities across racial and ethnic groups in multiple myeloma patients.

Authors:  Alexandra J Greenberg; S Vincent Rajkumar
Journal:  Int J Hematol       Date:  2012-03-09       Impact factor: 2.490

2.  Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

3.  Occurrence of serum M-protein species in Japanese patients older than 50 years based on relative mobility in cellulose acetate membrane electrophoresis.

Authors:  Y Kurihara; K Shiba; Y Fukumura; I Kobayashi; S Kamei
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 4.  Prevalence, clinical aspects, and natural history of IgM MGUS.

Authors:  Mary L McMaster; Ola Landgren
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

Review 5.  Does my patient with a serum monoclonal spike have multiple myeloma?

Authors:  Giada Bianchi; Irene M Ghobrial
Journal:  Hematol Oncol Clin North Am       Date:  2012-04       Impact factor: 3.722

6.  Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.

Authors:  Ingigerður S Sverrisdóttir; Sigrún H Lund; Ingemar Turesson; Magnus Björkholm; Lynn R Goldin; Ola Landgren; Sigurður Y Kristinsson
Journal:  Br J Haematol       Date:  2019-03-24       Impact factor: 6.998

7.  Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications.

Authors:  Giada Bianchi; Robert A Kyle; Colin L Colby; Dirk R Larson; Shaji Kumar; Jerry A Katzmann; Angela Dispenzieri; Terry M Therneau; James R Cerhan; L Joseph Melton; S Vincent Rajkumar
Journal:  Blood       Date:  2010-05-21       Impact factor: 22.113

Review 8.  Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma.

Authors:  Sham Mailankody; Esther Mena; Constance M Yuan; Arun Balakumaran; W Michael Kuehl; Ola Landgren
Journal:  Leuk Lymphoma       Date:  2010-10-20

Review 9.  Cancer in Jews: introduction and overview.

Authors:  Henry T Lynch; Wendy S Rubinstein; Gershon Y Locker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 10.  Prevalence of monoclonal gammopathy of undetermined significance: a systematic review.

Authors:  Rishi K Wadhera; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2010-08-16       Impact factor: 7.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.